Biogen Inc
Shares producing the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & extra
In this short article GNRC CCOI PACW Follow your most loved stocksGenerate No cost ACCOUNT basic watch of a Starbucks retail outlet on September 15, 2022 in Plainview, New York Bruce Bennett | Getty Visuals Information | Getty Illustrations or photos Verify out the businesses making headlines in premarket trading. Eli Lilly — The pharmaceutical […]
Read More
Bipartisan attorneys general call on Medicare to cover Alzheimer’s treatments
The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Democratic and Republican attorneys general in nearly half of U.S. states are calling on Medicare to provide unrestricted coverage of antibody treatments for Alzheimer’s disease, according to a letter released Monday. The push […]
Read More
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps years for a diagnosis. The U.S. health-care system is […]
Read More
Alzheimer’s: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing to be administrator of the Centers for Medicare & Medicaid Services in Washington on Thursday, April 15, 2021. Caroline Brehman | CQ-Roll Call, Inc. | Getty Images Medicare will cover the new Alzheimer’s treatment Leqembi for all patients eligible under the medication’s label […]
Read More
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen isn’t worried about competing with Eli Lilly as they both attempt to bring an Alzheimer’s drug to the market, Biogen’s CEO said Tuesday. “I think it will be good if there are […]
Read More
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration on Tuesday granted accelerated approval for Biogen‘s drug tofersen, which treats a rare and aggressive form of the disease known as ALS. Accelerated approval is an FDA designation […]
Read More
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Research at Biogen Source: Biogen Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows. The Japanese drugmaker and its partner Biogen last week released an additional analysis of clinical trials of the monoclonal antibody drug, which is also known as lecanemab. Alzheimer’s disease continued to progress at a slower rate […]
Read More
Eli Lilly says experimental Alzheimer’s drug reduces brain plaque in early study
Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli Lilly‘s experimental Alzheimer’s drug lowered levels of brain plaque in patients who are in the earliest […]
Read More
FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration’s independent panel of advisors on Wednesday voted against the effectiveness of Biogen’s investigational ALS drug for a rare and aggressive form of the disease. The drug tofersen […]
Read More